Checkpoint inhibitors seem safe against cancer in HIV patients

Previously, they were excluded from clinical trials

In HIV-infected patients with a variety of advanced cancers, immune-checkpoint inhibitors appear to be effective and add no new risks, according to a new systematic review.

HIV virus

As Dr Chul Kim of Georgetown University, in Washington, DC, said by email, using checkpoint inhibitors "for the treatment of advanced-stage cancer in patients with HIV infection was associated with no new safety signals," and "may be a safe and efficacious treatment option in this patient population."